FGF2 and breast carcinoma: In conclusion, the bFGF-induced miR-29a-SUV420H2 axis generated a significant effect on breast cancer cells EMT, migration and invasion in vitro and tumor dissemination in vivo, which provided a potential target for breast cancer therapy in the future.